1. Walker, FS (1985). Azapropazone, and related benzotrianzes. In: Rainsford, KD (ed), And-Inflammatory and Anti-Rheumatic Drugs, Vol. II. (Boca Raton, FL.: CRC Press), pp. 1–32
2. Rainsford, KD, Davies A, Mundy, L and Ginsburg, I (1989). Comparative effects of azapropazone on cellular events at inflamed sites. Influence on joint pathology in arthritic rats, leucocyte Superoxide and eicosanoid production, platelet aggregation, synthesis of cartilage proteoglycans, synovial production and actions of interleukin-1 in cartilage resorption correlated with drug uptake into cartilage in-vitro. J Pharm Pharmacol, 41, 322–30
3. Rainsford, KD (1989). Concepts of the mode of action and toxicity of anti-inflammatory drugs. A basis for safer and more selective therapy, and for future drug developments. In: Rainsford, KD and Velo, GP (eds), New Developments in Anti-Rheumatic Therapy. (Lancaster, UK: Kluwer Academic Publishers), pp. 37–92
4. Famaey, J-P (1987). Synovial anti-inflammatory and anti-rheumatic drug levels: importance in therapeutic efficacy. In: Lewis, AJ and Furst, DE (eds), Nonsteroidal Anti-Inflammatory Drugs, Mechanisms and Clinical Use. (New York & Basel: Marcel Dekker), pp. 201–14
5. Kitchen, EA, Dawson, W, Rainsford, KD and Cawston, T (1985). Inflammation and possible modes of anti-inflammatory drugs. In: Rainsford, KD (ed), Anti-Inflammatory and Anti-Rheumatic Drugs, Vol. I. (Boca Raton, FL: CRC Press), 21–87